Skip to main content
Log in

Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters

  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To assess preoperative short-course radiotherapy (SCR) tumor response in locally advanced rectal cancer (LARC) by means of Standardized Index of Shape (SIS) by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), apparent diffusion coefficient (ADC), intravoxel incoherent motion (IVIM) and diffusion kurtosis imaging (DKI) parameters derived from diffusion-weighted MRI (DW-MRI).

Materials and methods

Thirty-four patients with LARC who underwent MRI scans before and after SCR followed by delayed surgery, retrospectively, were enrolled. SIS, ADC, IVIM parameters [tissue diffusion (Dt), pseudo-diffusion (Dp), perfusion fraction (fp)] and DKI parameters [mean diffusivity (MD), mean of diffusional kurtosis (MK)] were calculated for each patient. IVIM parameters were estimated using two methods, namely conventional biexponential fitting (CBFM) and variable projection (VARPRO). After surgery, the pathological TNM and tumor regression grade (TRG) were estimated. For each parameter, percentage changes between before and after SCR were evaluated. Furthermore, an artificial neural network was trained for outcome prediction. Nonparametric sample tests and receiver operating characteristic curve (ROC) analysis were performed.

Results

Fifteen patients were classified as responders (TRG ≤ 2) and 19 as not responders (TRG > 3). Seven patients had TRG 1 (pathological complete response, pCR). Mean and standard deviation values of pre-treatment CBFM Dp and mean value of VARPRO Dp pre-treatment showed statistically significant differences to predict pCR. (p value at Mann–Whitney test was 0.05, 0.03 and 0.008, respectively.) Exclusively SIS percentage change showed significant differences between responder and non-responder patients after SCR (p value << 0.001) and to assess pCR after SCR (p value << 0.001). The best results to predict pCR were obtained by VARPRO Fp mean value pre-treatment with area under ROC of 0.84, a sensitivity of 96.4%, a specificity of 71.4%, a positive predictive value (PPV) of 92.9%, a negative predictive value (NPV) of 83.3% and an accuracy of 91.2%. The best results to assess after treatment complete pathological response were obtained by SIS with an area under ROC of 0.89, a sensitivity of 85.7%, a specificity of 92.6%, a PPV of 75.0%, a NPV of 96.1% and an accuracy of 91.2%. Moreover, the best results to differentiate after treatment responders vs. non-responders were obtained by SIS with an area under ROC of 0.94, a sensitivity of 93.3%, a specificity of 84.2%, a PPV of 82.4%, a NPV of 94.1% and an accuracy of 88.2%. Promising initial results were obtained using a decision tree tested with all ADC, IVIM and DKI extracted parameter: we reached high accuracy to assess pathological complete response after SCR in LARC (an accuracy of 85.3% to assess pathological complete response after SCR using VARPRO Dp mean value post-treatment, ADC standard deviation value pre-treatment, MD standard deviation value post-treatment).

Conclusion

SIS is a hopeful DCE-MRI angiogenic biomarker to assess preoperative treatment response after SCR with delayed surgery. Furthermore, an important prognostic role was obtained by VARPRO Fp mean value pre-treatment and by a decision tree composed by diffusion parameters derived by DWI and DKI to assess pathological complete response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Data availability

All data were present in the text of manuscript.

Abbreviations

AUC:

Area under ROC curve

CTV:

Clinical target volume

CT:

Computed tomography

CBFM:

Conventional biexponential fitting

DCE-MRI:

Dynamic contrast-enhanced magnetic resonance imaging

DWI:

Diffusion-weighted imaging

DKI:

Diffusion kurtosis imaging

D t :

Tissue diffusion

D p :

Pseudo-diffusion

f p :

Perfusion fraction

IMRT:

Intensity-modulated radiation therapy

IVIM:

Intravoxel incoherent motion

LARC:

Locally advanced rectal cancer

MD:

Mean diffusivity

MK:

Mean of diffusional kurtosis

MLC:

Multileaf collimators

MSD:

Maximum signal difference

NPV:

Negative predictive value

pCR:

pathological complete response

pCRT:

Preoperative chemo-radiation therapy

PPV:

Positive predictive value

ROC:

RECEIVER operating characteristic

ROI:

Regions of interest

SCR:

Short-course radiotherapy

SCRDS:

Short-course radiotherapy with delayed surgery

SIS:

Standardized Index of Shape

TRG:

Tumor regression grade

WOS:

Washout slope

VARPRO:

Variable projection

VOI:

Volume of interest

References

  1. Avallone A, Aloj L, Delrio P, et al. (2013) Multidisciplinary approach to rectal cancer: are we ready for selective treatment strategies? Anticancer Agents Med Chem 13(6):852–860

    Article  CAS  PubMed  Google Scholar 

  2. Avallone A, Delrio P, Guida C, et al. (2006) Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study. Br J Cancer 94(12):1809–1815

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Delrio P, Avallone A, Guida C, et al. (2005) Multidisciplinary approach to locally advanced rectal cancer: results of a single institution trial. Suppl Tumori. 4(3):S8.

  4. Zhou ZR, Liu SX, Zhang TS, et al. (2014) Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis. Surg Oncol 23(4):211–221

    Article  PubMed  Google Scholar 

  5. Latkauskas T, Pauzas H, Gineikiene I, et al. (2012) Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery. Colorectal Dis 14(3):294–298

    Article  CAS  PubMed  Google Scholar 

  6. Bujko K, Kolodziejczyk M (2008) The 5 × 5 Gy with delayed surgery in non-resectable rectal cancer: a new treatment option. Radiother Oncol 87(3):311–313

    Article  PubMed  Google Scholar 

  7. Beppu N, Matsubara N, Noda M, et al. (2015) Short-course radiotherapy with delayed surgery versus conventional chemoradiotherapy: a comparison of the short- and long-term outcomes in patients with T3 rectal cancer. Surgery 158(1):225–235.

  8. Pettersson D, Holm T, Iversen H, et al. (2012) Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg 99(4):577–583

    Article  CAS  PubMed  Google Scholar 

  9. Pettersson D, Lörinc E, Holm T, et al. (2015) Tumour regression in the randomized Stockholm III trial of radiotherapy regimens for rectal cancer. Br J Surg 102(8):972–978; discussion 8.

  10. Radu C, Berglund A, Pahlman L, Glimelius B (2008) Short-course preoperative radiotherapy with delayed surgery in rectal cancer—a retrospective study. Radiother Oncol 87(3):343–349

    Article  PubMed  Google Scholar 

  11. Hatfield P, Hingorani M, Radhakrishna G, et al. (2009) Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol 92(2):210–214

    Article  PubMed  Google Scholar 

  12. Valentini V, Glimelius B, Haustermans K, et al. (2014) EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist’s expert review. Radiother Oncol 110(1):195–198

    Article  PubMed  Google Scholar 

  13. Avallone A, Piccirillo MC, Delrio P, et al. (2014) Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid–short Radiotherapy–rectum 3rd trial). BMC Cancer 24(14):875

    Article  CAS  Google Scholar 

  14. Heo SH, Kim JW, Shin SS, Jeong YY, Kang H-K (2014) Multimodal imaging evaluation in staging of rectal cancer. World J Gastroenterol 20(15):4244–4255

    Article  PubMed  PubMed Central  Google Scholar 

  15. Fusco R, Sansone M, Petrillo M, et al. (2004) Role of magnetic resonance imaging in locally advanced rectal cancer, colorectal cancer—surgery, diagnostics and treatment. InTech. https://doi.org/10.5772/56831.

  16. Beets-Tan RG, Beets GL (2004) Rectal cancer: review with emphasis on MR imaging. Radiology 232(2):335–346

    Article  PubMed  Google Scholar 

  17. Leach MO, Brindle KM, Evelhoch JL, et al. (2005) The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 92(9):1599–1610

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Petrillo A, Fusco R, Petrillo M, et al. (2015) Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC. Eur Radiol

  19. Petrillo M, Fusco R, Catalano O, et al. (2015) MRI for assessing response to neoadjuvant therapy in locally advanced rectal cancer using DCE-MR and DW-MR data sets: a preliminary report. Biomed Res Int 2015:514740

    Article  PubMed  PubMed Central  Google Scholar 

  20. Beets-Tan RG, Beets GL (2014) MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer. Nat Rev Gastroenterol Hepatol 11(8):480–488

    Article  CAS  PubMed  Google Scholar 

  21. Phongkitkarun S, Tohmad U, Larbcharoensub N, et al. (2016) DCE-MRI-derived parameters as predictors of response to neo-adjuvant chemoradiation treatment of rectal carcinoma. J Med Assoc Thai. 99(3):338–347

    PubMed  Google Scholar 

  22. Petrillo A, Fusco R, Granata V, et al. (2017) MR imaging perfusion and diffusion analysis to assess preoperative Short Course Radiotherapy response in locally advanced rectal cancer: Standardized Index of Shape by DCE-MRI and intravoxel incoherent motion-derived parameters by DW-MRI. Med Oncol 34(12):198

    Article  PubMed  Google Scholar 

  23. Le Bihan D, Breton E, Lallemand D, et al. (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168(2):497–505

    Article  PubMed  Google Scholar 

  24. Le Bihan D, Breton E, Lallemand D, et al. (1986) MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161(2):401–407

    Article  PubMed  Google Scholar 

  25. Oto A, Yang C, Kayhan A, et al. (2011) Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am J Roentgenol 197(6):1382–1390

    Article  PubMed  Google Scholar 

  26. Curvo-Semedo L, Lambregts DM, Maas M, et al. (2011) Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy–conventional MR volumetry versus diffusion-weighted MR imaging. Radiology 260(3):734–743

    Article  PubMed  Google Scholar 

  27. Luciani A, Vignaud A, Cavet M, et al. (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 249(3):891–899

  28. Wirestam R, Borg M, Brockstedt S, et al. (2001) Perfusion-related parameters in intravoxel incoherent motion MR imaging compared with CBV and CBF measured by dynamic susceptibility contrast MR technique. Acta Radiol 42(2):123–128

    Article  CAS  PubMed  Google Scholar 

  29. Granata V, Fusco R, Catalano O, et al. (2016) Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for Hepatocellular carcinoma: correlation with histologic grade. Oncotarget 7(48):79357–79364

    Article  PubMed  PubMed Central  Google Scholar 

  30. Granata V, Fusco R, Catalano O, et al. (2015) Early assessment of colorectal cancer patients with liver metastases treated with antiangiogenic drugs: the role of intravoxel incoherent motion in diffusion-weighted imaging. PLoS ONE 10(11):e0142876

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Koh DM, Collins DJ, Orton MR (2011) Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 196(6):1351–1361

    Article  PubMed  Google Scholar 

  32. Jensen JH, Helpern JA (2010) MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed 23:698–710

    Article  PubMed  PubMed Central  Google Scholar 

  33. Dresen RC, Beets GL, Rutten HJ, et al. (2009) Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 252(1):81–91

    Article  Google Scholar 

  34. SIS Tool by Antonella Petrillo available requiring at an.petrillo@istitutotumori.na.it

  35. Fusco R, Petrillo A, Petrillo M, Sansone M (2013) Use of tracer kinetic models for selection of semi-quantitative features for DCE-MRI data classification. Appl Magn Reson 44(11):1311–1324

    Article  CAS  Google Scholar 

  36. Fusco R, Sansone M, Petrillo A (2017) A comparison of fitting algorithms for diffusion-weighted MRI data analysis using an intravoxel incoherent motion model. MAGMA 30(2):113–120

    Article  CAS  PubMed  Google Scholar 

  37. Seber GAF, Wild CJ (1989) Nonlinear regression. New York: Wiley

    Book  Google Scholar 

  38. Andreola S, Leo E, Belli F, et al. (2001) Adenocarcinoma of the lower third of the rectum surgically treated with a <10-mm distal clearance: preliminary results in 35 N0 patients. Ann Surg Oncol 8(7):611–615

    Article  CAS  PubMed  Google Scholar 

  39. Mandard AM, Dalibard F, Mandard JC, et al. (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73(11):2680–2686

    Article  CAS  PubMed  Google Scholar 

  40. Fukunaga K (1990) Introduction to statistical pattern recognition. Cambridge: Academic Press

    Google Scholar 

  41. Duda RO, Hart PE, Stork DG (2001) Pattern classification. New York: Wiley

    Google Scholar 

  42. Theodoridis S, Koutroumbas K (2003) Pattern recognition. Cambridge: Academic Press

    Google Scholar 

  43. Fusco R, Sansone M, Filice S, et al. (2016) Pattern recognition approaches for breast cancer DCE-MRI classification: a systematic review. J Med Biol Eng 36(4):449–459

    Article  PubMed  PubMed Central  Google Scholar 

  44. Choi MH, Oh SN, Rha SE, et al. (2015) Diffusion-weighted imaging: apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer. J Magn Reson Imaging . https://doi.org/10.1002/jmri.25117

    Article  PubMed  Google Scholar 

  45. Doi H, Beppu N, Kato T, et al. (2015) Diffusion-weighted magnetic resonance imaging for prediction of tumor response to neoadjuvant chemoradiotherapy using irinotecan plus S-1 for rectal cancer. Mol Clin Oncol 3(5):1129–1134

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Nougaret S, Vargas HA, Lakhman Y, et al. (2016) Intravoxel incoherent motion-derived histogram metrics for assessment of response after combined chemotherapy and radiation therapy in rectal cancer: initial experience and comparison between single-section and volumetric analyses. Radiology 280(2):446–454

    Article  PubMed  Google Scholar 

  47. Petrillo A, Fusco R, Petrillo M, et al. (2017) Standardized Index of Shape (DCE-MRI) and standardized uptake value (PET/CT): two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile. Oncotarget 8(5):8143–8153

    Article  PubMed  Google Scholar 

  48. Iima M, Le Bihan D (2016) Clinical intravoxel incoherent motion and diffusion MR imaging: past, present, and future. Radiology 278(1):13–32

    Article  PubMed  Google Scholar 

  49. Rega D, Pecori B, Scala D, et al. (2016) Evaluation of tumor response after short-course radiotherapy and delayed surgery for rectal cancer. PLoS ONE 11(8):e0160732

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Pecori B, Lastoria S, Caracò C, et al. (2017) Sequential PET/CT with [18F]-FDG predicts pathological tumor response to preoperative short course radiotherapy with delayed surgery in patients with locally advanced rectal cancer using logistic regression analysis. PLoS ONE 12(1):e0169462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Siegel R, Dresel S, Koswig S, et al. (2008) Response to preoperative short-course radiotherapy in locally advanced rectal cancer: value of f-fluorodeoxyglucose positron emission tomography. Onkologie 31(4):166–172

    Article  PubMed  Google Scholar 

  52. Janssen MH, Ollers MC, van Stiphout RG, et al. (2010) Evaluation of early metabolic responses in rectal cancer during combined radiochemotherapy or radiotherapy alone: sequential FDG-PET-CT findings. Radiother Oncol 94(2):151–155

    Article  PubMed  Google Scholar 

  53. Yu J, Xu Q, Song JC, et al. (2017) The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 27(5):1848–1857

    Article  PubMed  Google Scholar 

  54. Hu F, Tang W, Sun Y, et al. (2017) The value of diffusion kurtosis imaging in assessing pathological complete response to neoadjuvant chemoradiation therapy in rectal cancer: a comparison with conventional diffusion-weighted imaging. Oncotarget 8(43):75597–75606

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Writing/editorial support in the preparation of this manuscript was provided by Di Giovanni Manuela, University of Technology, Sydney, Australia.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to this work for patient’s enrollment, diagnostic and therapeutic procedures. RF performed image post-processing, statistical analysis and manuscript editing.

Corresponding author

Correspondence to Roberta Fusco.

Ethics declarations

Funding

No funding.

Conflict of interest

Each author declares that has no conflict of interest. Exclusively Robert Grimm (Robert.grimm@siemens.com) is an employee of Siemens Healthcare for development of the MR Body Diffusion Toolbox, a post-processing software to calculate IVIM and Kurtosis maps.

Ethics approval and consent to participate

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent was obtained from all individual participants included in the study.

Consent for publication

Consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fusco, R., Sansone, M., Granata, V. et al. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters. Abdom Radiol 44, 3683–3700 (2019). https://doi.org/10.1007/s00261-018-1801-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-018-1801-z

Keywords

Navigation